April 30, 2017 7:37 PM ET


Company Overview of Abbott Healthcare Private Limited

Company Overview

Abbott Healthcare Private Limited develops nutritional products, laboratory diagnostics, medical devices, and pharmaceutical therapies. The company develops products in areas, such as antibiotic, respiratory, gastro, dermat, nutritional, parenteral, anti parasitic, gyne, ophthalmology/otolaryngology, anti cancer, cardiac, anti diabetic, psychiatry, NSAIDS/pain, hormonal, anti parasitic, and stomatologicals. It produces formulations and dosage forms, such as tablets, which include uncoated and coated (film and sugar coated); hard gelatin capsules filled with granules, powders, pellets, and tablets; soft gelatin capsules; liquid orals, syrups, and suspensions; topicals, which include lotions a...

1st Floor, D Mart Building

Goregaon Mulund Link Road

Mulund (West)

Mumbai,  400 080


Founded in 1997


91 22 3953 6666


91 22 3953 6665

Key Executives for Abbott Healthcare Private Limited

Chairman of Abbott Laboratories and Chief Executive officer of Abbott Laboratories
Age: 61
Compensation as of Fiscal Year 2016.

Abbott Healthcare Private Limited Key Developments

Crime Investigation Department Registers Case against Abbott Health Care Pvt Ltd for Smuggling INR 576 Million Worth Cough Syrup into Bangladesh

Crime Investigation Department has registered a case against Abbott Health Care Pvt Ltd. and their associates for smuggling INR 576 million worth cough syrup containing narcotic components into Bangladesh using fake bills. Based on an alert by customs sleuths based in Shillong six months ago, the Drugs Control Administration (DCA), Telangana, launched a probe after 5,100 bottles of Phensedyl cough syrup were seized by the customs sleuths while being smuggled into Bangladesh. The batch numbers on the seized cough syrup bottles indicated that they were supposed to be marketed in Nizamabad. According to director of DCA, Telangana, Akun Sabharwal, Phensedyl syrup contains the narcotic compound codeine (isolated from opium) and it was being used for substance abuse in Bangladesh, where sale of alcohol is prohibited. The DCA registered nine cases against Abbott health Care Pvt Ltd. and others. As they have no power to book cases under the NDPS Act or arrest the accused, the DCA has lodged a complaint with the CID, Telangana. Based on the details submitted by DCA, the CID sleuths registered a case under sections 8, 21, 22 & 29 of the NDPS Act and sections 468 (forgery for the purpose of cheating) and 471 (using as genuine a forged document) of the Indian Penal Code (IPC) June 8, 2015.

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Abbott Healthcare Private Limited, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.